SCHEMBL5222827

SCHEMBL5222827

O=C(O)c1cccc([N+](=O)[O-])c1N1CCCCC1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.50
ALDH1A1 P00352 4/20 0.43
POLB P06746 2/20 0.43
KDM4E B2RXH2 2/20 0.43
HPGD P15428 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
PKM P14618 1/20 0.42
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
GAA P10253 1/20 0.40
DNA2 P51530 1/20 0.40
CASP6 P55212 1/20 0.40
CTDSP1 Q9GZU7 1/20 0.40
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27613664 0.80 ALDH1A1 (0.58) TSHRALDH1A1HPGDCYP1A2CYP3A4
SCHEMBL29512644 0.80 ALDH1A1 (0.49) ALDH1A1POLBKDM4EHPGDCYP1A2
SCHEMBL6006263 0.80 TSHR (0.56) TSHRALDH1A1KDM4EHPGDPKM
SCHEMBL17185095 0.74 ALDH1A1 (0.51) TSHRALDH1A1KDM4EHPGDCYP1A2
SCHEMBL16057602 0.72 ALDH1A1 (0.49) TSHRALDH1A1HPGDCYP1A2CYP3A4
SCHEMBL16653775 0.72 KDM4E (0.57) TSHRALDH1A1KDM4ECYP1A2CYP2C9
SCHEMBL31056512 0.72 APOBEC3A (0.52) ALDH1A1POLBHPGDCYP1A2CYP3A4
SCHEMBL29805501 0.72 KDM4E (0.60) TSHRALDH1A1POLBKDM4EHPGD
SCHEMBL15956314 0.71 KDM4E (0.53) ALDH1A1POLBKDM4EHPGDCYP1A2
SCHEMBL17769843 0.70 TSHR (0.51) TSHRALDH1A1POLBKDM4EPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed